Günstig Trikots Fußball Kinder, Laut Fabrizio Romano ist Barcelona sehr an Aston Villa-Star Carney Chukwuemeka interessiert. Der Brite, der kurz vor dem letzten Vertragsjahr steht, gilt als Spieler mit großem Potenzial und könnte von der FIFA für das Training im Januar-Transferfenster bezahlt werden. Chukwuemeka wurde in Österreich als Sohn nigerianischer Eltern geboren, vertritt England aber auf U19-Ebene. Er machte seine ersten Schritte im Fußball in Northampton Town, bevor er 2016 zu Villa wechselte und 2021 sein Debüt in der Premier League gab. Seitdem hat der Mittelfeldspieler insgesamt 16 Spiele für die erste Mannschaft bestritten. Das finanziell angeschlagene Barcelona ist bestrebt, den Jugendmarkt zu nutzen, um seinen Kader in den kommenden Spielzeiten zu stärken, und Spieler wie Chukvimeka werden von großem Interesse sein. Xavi Hernandez hat auch seine Bereitschaft gezeigt, Spielern, die er seiner Meinung nach verdient, Chancen und Minuten zu geben.
Italien Trikots, Laut Marca drängen zwei lateinamerikanische Vereine darauf, den Free Agent Dani Alves zu verpflichten, nachdem sein Vertrag mit Barcelona Ende Juni ausgelaufen ist. Der mexikanische Klub Club America hat dem Brasilianer einen Deal über 3 Millionen Dollar pro Saison angeboten, um nach Mexiko-Stadt zu kommen, ein Deal, der den 39-jährigen Rechtsverteidiger zum vierthöchstbezahlten Spieler in La Liga machen würde. Auch Brasiliens Atlético Paraná interessiert sich für ihn. Alves – der Spieler mit den meisten Auszeichnungen in der Geschichte des Fußballs – ist bestrebt, einen Verein zu finden, der ihm helfen kann, ein gutes Wettbewerbsniveau aufrechtzuerhalten und sich bei der bevorstehenden Weltmeisterschaft in Katar einen Platz in der brasilianischen Nationalmannschaft zu sichern. Er hat bisher 125 Auftritte.
Fußballtrikots für Kinder, Alves hofft, dass es bei Barcelona sein wird, nur wenn der katalanische Klub beschließt, den Sechsmonatsvertrag, den er unterzeichnet hat, als er letzten Winter aus Sao Paulo zum Klub zurückkehrte, nicht zu verlängern. In der Rückrunde der Saison 2021/22 bestritt er 15 Spiele für Barcelona und steuerte dabei 1 Tor und 3 Vorlagen bei. „Ich bin nicht traurig gegangen“, sagte Alves dem Guardian. "Ich bin sehr glücklich, wieder in Barcelona zu sein. Ich habe von fünf Jahren geträumt und möchte in diesem Moment leben. Das einzige, was mir nicht gefallen hat, war, wie mein Abgang gehandhabt wurde. "Seit ich hier bin, Das habe ich ganz klar gesagt. Als 20-Jähriger möchte ich, dass die Dinge positiv angegangen werden und nichts zurückhalten. Aber der Klub hat in den letzten Jahren Verbrechen begangen. Barcelona kümmert sich nicht darum, wer für den Verein Geschichte schreibt. Als Spieler wünsche ich mir, dass Barcelona die Dinge anders macht. „Ich spreche nicht von mir, weil meine Situation eine andere ist. Ich bin Xavi [Hernandez] und dem Präsidenten für immer dankbar, dass sie mich zurückgebracht haben. Unglaublich nachdenklicher junger Mann. Aber es muss die Offsite-Arbeit verbessern. Diese Mentalität ist das genaue Gegenteil von dem, was wir vor ein paar Jahren etabliert haben: „Alles, was auf dem Platz passiert, spiegelt das wider, was draußen passiert kollektives Spiel. Und das wurde im Club ignoriert.
Posts
The new market research report titled ‘Viral Clearance and Viral Testing Services Market’, published by Roots Analysis offers a comprehensive study of the Viral Clearance and Viral Testing Services industry, while estimating the overall market size and the size and share of the key regional segments of the global market over historical period, as well as the projected timeline of 2023-2035.
The Viral Clearance and Viral Testing Services market is expected to deliver robust growth over the forecast period, registering an impressive CAGR of 10%. The anticipated market growth is accredited to the significant surge in demand across the regional and global markets for the products and services offered by the Viral Clearance and Viral Testing Services industry. The latest study provides readers with a granular analysis of the major developmental elements of the global market, potential business avenues, and the overall market dynamics. The report has been specially curated to offer a deep understanding of the competitive terrain of the global market, highlighting the leading market rivals, their market positions, product portfolios, gross revenue shares, profit margins, pricing analysis, sales network & distribution channels, and financial standing.
Segmentation by Scale of Operation
Discovery Phase
Preclinical Phase
Clinical Phase
Segmentation by Method of Viral Clearance and Testing
Viral Detection
Viral Inactivation
Viral Removal
Key Companies Profiled
Charles River Laboratories
Eurofins Scientific
Microbac Laboratories
Nelson Labs
Pall
Syngene International
Texcell
Roots Analysis is also offering complimentary Excel Data Packs for
Market Landscape Analysis
Company Competitiveness Analysis
Patent Analysis
Recent Developments and Initiatives
Market Forecast and Opportunity Analysis
The latest research report specializes in the in-depth analysis of the macroeconomic and microeconomic factors affecting the Viral Clearance and Viral Testing Services market development. The report also concentrates on the regulatory framework that is shaping the future of the global market. New and existing pricing structures, emerging application areas, and upcoming investment opportunities have also been detailed in the report. The report further studies the projected growth factors that are expected to influence the market dynamics over the forecast timeframe.
The study is inclusive of a comprehensive analysis of the commonly used marketing and promotional strategies adopted by the key market players. Taking into account the existing market development factors, historical events, and recent market trends, the study presents a balanced opinion on the future scenario of the Viral Clearance and Viral Testing Services market. It thus supports its opinion by discussing the key corporate strategies, such as mergers & acquisitions, takeovers, joint ventures, and strategic alliances, used by the market players to strengthen their global footprint.
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Viral Clearance and Viral Testing Services market.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/viral-clearance-and-testing-services-market.html
You may also be interested in the following titles:
Deep Learning Market in Drug Discovery and Diagnostics
Cell Therapy Media, Cell Therapy Kits, Cell Therapy Reagents and Cell Therapy Surface Market
You may also like to learn what our experts are sharing in Roots educational series:
Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?
SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
New Jordan 2020, If 1971 was the time when the Nike brand was officially launched, then in 1982, the Air Force 1 was also released. That was only 11 years later, and the Air Force 1 was one of the company's first product lines. The Nike Air Force 1 was launched by then Nike designer Bruce Kilgore as a basketball player's line of shoes. Of course, the product at the time was very successful. Following the introduction of sneakers such as "London" and "Paris", Nike has launched another design for the 40th anniversary, the Air Force 1 Mid "Berlin".
2020 Cheap Jordans, Similar to its predecessor, the upcoming design will subtly pay homage to the German capital through its colour scheme and brand accents. Since Berlin is informally known as the "Grey City", with granite finishes for most of its buildings and famous for its cloudy skies in autumn and winter, the shoe will feature "Cave" on the leather upper and midsole. Stone" finish shade. The bold black on the laces and suede overlay represents the black bear on the city flag and the famous nightlife, while the white features the Nike Swoosh logo on the cheekbones, shoes, heel tab and tongue. Finally, the metal laces at the eyelets will be stylized as the city logo, and the teal embroidered area code "030" will help complete the overall aesthetic of the sporty version. the sport.
Retro Jordan 2021, It is said that in order to match the previously revealed "Bred" colorway, Jordan Brand's Air Jordan 1 LV8D Eleised will also be available in "Wolf Grey" and "Onyx" two colors. Also available in a two-tone design, the latest version features the classic women's Air Jordan 1 with a clean white leather upper with contrasting overlays and toe cap. Other details of the shoe include embroidered wings on the back, and a nubuck midsole. Completing the shoe's design is a chunky white midsole and an enlarged contrasting rubber outsole. The sneaker features a white leather upper with a tan leather overlay that gives the sneaker a unique two-tone look. The Air Jordan brand is minimalist with a single Jumpman on the heel of the midsole, no tongue tab, and a silhouette of the Wings logo stitched on the sole. The sneaker's standout feature is an exaggerated white midsole and tan outsole that complement the shoe.
jordan shoes 2019, In addition to the Air Jordan 1 LV8D Eleised Onyx, Jordan Brand will also release the Air Jordan 1 LV8D Eleised Wolf Grey. Here is its official picture. Designed for women, the Air Jordan 1 LV8D Eleised features a chunky sole for a taller look. This shoe features a white and grey leather upper with a perforated toe cap and an embroidered Wings logo on the heel. Other details include a cork footbed, white midsole, and grey and tan rubber outsole.
New Jordan 2020, Born in the early '80s, the Air Jordan 1 was designed by Peter C. Moore, and apparently it wasn't one of Michael's favorite sneakers. In its more than three decades of existence, this classic design has remained consistently relevant. Thanks to Off-White founder Virgil Abloh, the Nike Air Jordan 1 is a fascinating innovation. Whether it's a collaboration like this or a regular release, it seems that sneaker lovers will never tire of this top-notch design. Based on initial images that have surfaced over the past few years, we now have a detailed look at the Air Jordan 1 Retro High OG "Yellow Toe" version. Jordan Brand's release this summer will feature eye-catching designs in the popular "Black Toe" color block.
2020 Cheap Jordans, This Air Jordan 1 Retro High OG "Yellow Toe" will feature a premium white suede upper with a yellow toe, heel and ankle visor. Black leather details that complete the tri-color look will appear on the collar, laces and midfoot. Next, the branding will include the Wings logo on the collar, tongue and printed lining. Finally, a combination of black laces, a solid white midsole, and a contrasting yellow rubber outsole completes the overall look of the shoe.
New Jordan Release, The Air Jordan 3 is credited with introducing the famous elephant print to the world. So how did you feel when Jordan Brand took it off the stock fenders? The change has been well-received so far, as it dates back to earlier releases such as the Air Jordan 3 "Mocha," a sneaker that initially launched with minor details and has since gained a cult following. The same style is also seen on the upcoming Air Jordan 3 "Muslin," a shoe whose color scheme may be too overwhelming. As mentioned earlier. The elephant print on the toe and heel fenders has been replaced with grey suede, which is joined by a chiffon-coloured canvas upper for a truly lifestyle-centric entry. The laces match the tongue, while the heel, lace eyelets and the heel portion of the midsole are slightly darker. Bulls Red completes the look as it is dedicated to the forefoot logo and eyelets.
Recent advancements in multiplexed profiling and tissue imaging methods have enabled the assessment of spatial heterogeneity in intact tissues; as a result, adoption of spatial omics solutions offering benefits over traditional methods, is increasing
Roots Analysis has announced the addition of “Spatial Genomics, Transcriptomics and Proteomics Solutions Market, 2022-2035” report to its list of offerings.
The Spatial Genomics Market report features an extensive study of the current market landscape and the likely future potential; associated with the spatial omics solutions market, over the next decade. The study also includes a detailed analysis of key drivers and trends within this evolving market. Amongst other elements, the report features:
A detailed overview of the overall market landscape of spatial omics solutions based on several relevant parameters.
A detailed overview of the overall market landscape of players engaged in offering spatial proteomics, transcriptomics and genomics solutions, based on year of establishment, company size, location of headquarters and regional landscape.
A detailed competitiveness analysis of products based on parameters, such as supplier power and product specifications.
Elaborate profiles of key players offering spatial omics solutions.
An analysis of the various partnerships related to spatial omics solutions inked by players engaged in this domain.
An in-depth analysis of patents related to spatial omics solutions, filed / granted, since 2003.
A detailed review of around 600 peer-reviewed, scientific articles related to research on spatial omics solutions.
An elaborate discussion on the various commercialization strategies that can be adopted by drug developers engaged in this domain, across different stages of therapy development, including prior to drug launch, at / during drug launch and post-marketing of the drug.
A detailed review of the overall landscape of the live cell instruments market, highlighting the contributions of industry players, along with information on their year of establishment, company size, geographical location of headquarters, ownership and instruments specific parameters.
A detailed review of the overall landscape of sequencing technologies market, highlighting the contributions of industry players, along with information on their year of establishment, company size, geographical location of headquarters, ownership and sequencers specific parameters.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of Solution
Instruments
Consumables
Services
Sample Type
DNA
RNA
Protein
Research Area
Oncological Disorders
Immunological Disorders
Neurological Diorders
Infectious Diseases
Others
End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Key Geographical Regions
North America
Europe
Asia-Pacific and Rest of the World
Key companies covered in the report
10x Genomics
Akoya Biosciences
Bruker
Canopy Biosciences
NanoString Technologies
Vizgen
Lunaphore Technologies
Molecular Machines & Industries (MMI)
Resolve Biosciences
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/spatial-genomics-market.html
You may also be interested in the following titles:
Cannabis Testing Market
Decentralized Clinical Trials / Virtual Clinical Trials Market
You may also like to learn what our experts are sharing in Roots educational series:
At-home Self-testing: A Giant Leap Towards Transformation in Diagnostic Sector
SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Owing to the growing number of clinical trials and complexities associated with patient enrollment, drug developers are increasingly relying on patient recruitment service providers to expediate the drug development timelines
Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Market (3rd Edition), 2022 – 2035.”
The report features an extensive study of companies engaged in offering patient recruitment services and patient retention services. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes:
A general overview of the clinical trials, patient recruitment process, patient recruitment associated services as well as the patient retention strategies employed to prevent drop-out of enrolled individuals from clinical trials.
A brief information on the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials.
A detailed assessment of the overall landscape of patient recruitment companies and patient retention companies offering these services.
A detailed competitiveness analysis of patient recruitment and retention service providers, segregated into three peer groups based on company size (small, mid-sized, and large and very large).
Elaborate profiles of prominent players offering patient recruitment and retention service, based in North America, Europe and Asia Pacific.
An analysis of the partnerships that have been inked by stakeholders engaged in this domain, from 2013-2022.
A review of the emerging trends in the patient recruitment industry, including the use of social media, mobile technologies, electronic health records (EHR), real-world evidence (RWE) and artificial intelligence.
A detailed discussion on the key growth opportunities in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years.
A case study on regulatory landscape of patient recruitment, highlighting the regulatory process, guidelines and framework.
A brief overview of patient recruitment in clinical trials focused on personalized medicines and rare diseases.
A detailed analysis of the annual demand for study participants, taking into account the target patient population in ongoing and planned clinical trials, sponsored by both industry and non-industry players.
A detailed assessment on the impact of the COVID-19 pandemic on the patient recruitment and retention services market.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Patient Recruitment Step
Pre-screening
Screening
Trial Phase
Phase I
Phase II
Phase III
Phase IV
Therapeutic Area
Cardiovascular Disorders
Oncological Disorders
Infectious Diseases
CNS Disorders
Respiratory Disorders
Hematological Disorders
Dermatological Disorders
Ophthalmic Disorders
Others
Key Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa
Rest of the World
Transcripts of interviews held with the following senior level representatives of stakeholder companies:
Susan Fitzpatrick-Napier (Founder and Director, TrialWire)
Kate Shaw (Chief Executive Officer and Founder) and Marco Lassandro (Marketing and Communications Manager, Innovative Trials)
Simon Klaasen (Co-founder and Managing Director, Link2Trials)
Stefan Mayer-Eggersmann (Chief Commercial Officer, Clariness)
Ken Shore (Chief Commercial Officer, Continuum Clinical)
Hagit Nof (Chief Operation Officer and Business Development Officer, nRollmed)
Paul Ivsin (Ex-Managing Director, Seeker Health)
Kasturi Lakhe (Inside Sales Specialist, EVERSANA)
Key companies covered in the report
BBK Worldwide
Continuum Clinical
IQVIA
United BioSource (UBC)
WCG ThreeWire
Clariness
Fidelis Research
Ignite Data
Innovative Trials
Orphan Reach
3H Medi Solution
Buzzreach
Current Medical Information Center (CMIC)
nRollmed
Trialfacts
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market/245.html
News article
Global Cell Free Expression Market
Learn from experts: do you know about these emerging industry trends?
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
4D Bioprinting Market: Key Trends
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnson@rootsanalysis.com
New Jordan 2020, Nike has been very active since the beginning of 2022 compared to the first half of last year. From Chinese New Year to Air Max Day, the brand can't keep up with all the new arrivals they're launching. One of the duos, Dunk Low "Setsubun," unfortunately got lost in the shuffle, missing the eponymous music festival for nearly a month. However, that did not delay the release of the colorway, as newly leaked official photos suggest there will be one soon. Setsubun, which translates to "sector of the season", is a celebration celebrated in early February. According to the Japanese lunar calendar, the festival is held the day before the beginning of spring. While Halloween is not a national holiday, many people still do rituals to drive away bad moods. Jifen, also known as the "Bean Throwing Festival," is best commemorated with additional graphics on the shoes. For example, the great horn master Tsuno Daishi has purple thread embroidered on the heel, while Swooshes replace his horns. Although the character's appearance may seem sinister, it does protect against evil and disease. Elsewhere, the imagery beneath the insole is inspired by the work of Edo-era artist Utagawa Kuniyoshi, whose vibrant colors depict the folk hero urn in action.
2020 Cheap Jordans, With countless variations, Nike is ready to deliver the Air Force 1 in its purest form, complemented by some trusted design strategies. In celebration of the Air Force 1's 40th anniversary, the shoe will be available in an official Vintage Edition, with sail and coconut cream to convey the old look we've identified decades ago. Nike kept some of the original elements, such as the silver-grey Swoosh and sole, as well as the tongue tab, while the midplate tried to replicate the nylon used in the original. To support its case, leather with a damaged finish embellishes the heel guard and stripes. With the Air Force 1 celebrating its 40th anniversary in 2022, we would have expected some collaborations with designers and stores. However, we haven't heard of any such move so far, but an influx of "GR" styles that will guarantee everyone has enough Air Force 1s.
Retro Jordan 2021, Even the limited edition can't beat the "Triple White" Air Force 1, arguably one of the most iconic pieces in the Nike collection. And, while the brand may be experimenting with unusual creative makeup for the 40th anniversary, most will probably stick to a more direct approach. The next pair, slightly modified from its neutral-dominant counterpart, is just that, offering an option for those who want something new but not too different. The shoes are almost entirely white, like they've been done a few times before. As usual, smooth leather wraps the toe, mid-panel and heel with matching laces, eye guards and tongue in between. While the sole mostly matches, the tread is darker to the touch, and the grey tones are also shown along the Swoosh, heel tab and associated branding.
jordan shoes 2019, Nike has yet to kick off the Air Force 1's 40th anniversary, as they're clearly preoccupied with Air Max Day. That hasn't stopped the company from announcing commemorative items, which include collaborations with Stussy, Civilist Berlin, and most likely Drake. Many other GRs are on the way, and more are being released every day, like this cannabis-made shade. Unlike what we're used to seeing, the silhouette looks handcrafted. The top is braided with a wide white thread that wraps everything from the toe. Even the construction of the Swoosh and heel tabs are similar, but they are colored in bright orange and blue, respectively. The bright green tongue is noticeably more typical, while the lower part of the sole is recycled, as can be seen from the faint spots.
In the beginning, Nike SB Dunk came from the college basketball court. At that time, due to the rise of stars such as Michael Jordan, the sport gained great popularity. This has also caused the University Basketball Village to receive a lot of attention and attention. In order to capture new markets, Nike released Nike Dunk-a sports shoe designed specifically for the college basketball team sponsored by Nike. These initial editions are all part of the "Be True To Your School" series. Each basketball team will receive a dunk corresponding to its team color. Nike Dunk Low always seems to be on fire at the beginning of the year. The "Street Vendor" collaboration, Strangeloves and Travis Scott both came out at the beginning of the new year, and they both created a buzz in the following months. If the recently announced Nike Dunk Low "Barber Shop" version is really retail in 2022, the same situation will definitely happen.
New Jordan 2020, Despite the name "Barbershop", the artificial fur material does not appear on the shoes. Instead, the smooth leather upper will be dyed dark black, and the heel will be engraved with patterns commonly used in art barbershops. Next, along the cheekbones, the piping has iconic red, white, and blue stripes, which respect the industry like those old-fashioned trimmers used to arm vampires. In addition, the light blue tone will decorate the lining and the Nike Swoosh logo, while the red tone will highlight the tip of the shoelace and the Nike logo on the tongue and heel. Finally, the combination of white midsole and blue outsole will help complete the aesthetic appearance of this pair of sports shoes.
2020 Cheap Jordans, You can give it to Nike's design team and let them always modernize their classic styles in a creative way. Therefore, there is no doubt that Dunk is the main focus of the brand in this era, and one of the latest color schemes to be put on the market in 2022 is Nike Dunk Low "Paisley", black with simple white. Most designs are covered in smooth black leather with white toe caps, quarter panels and collars. However, all this is still related to the dark color on the tongue, the mesh fabric and the swoosh accent decorated with a headscarf pattern. Below is an angel-toned midsole. However, the inner lining of the shoes is still white, and the Swooshes are decorated with a mustard flower pattern inspired by the guzheng turban. Below all of this, you can find a midsole, which is also painted to look like leather, and an all-black sole that strung its "panda" palette together.
jordan shoes 2019, Blazers are the sneakers of the line. Nike has been very popular recently-a bright release may be mentioned as a dedicated Serena Williams as well as a series of blazers with low whirlwind. Joining the ranks will be the new OFF-WHITE co-branded Nike Blazer colorway-with a bold Halloween name: "All Hallows Eve". This "Halloween Eve" color scheme comes in two tan/orange shades with a hint of blue. Since its first appearance in the 1970s, Nike Blazer Mid has released countless different versions. For its latest version, this first Nike basketball shoe will be more fashionable. This is due to its huge styling. Undoubtedly, inspired by the Off-White collaboration launched by Virgil Abloh in 2017, this design is almost a "colorless" arrangement. The suede covering on the toe and forefoot continues to maintain the original style. Next, the extremely conspicuous green tone will cover the entire Nike Swoosh logo on the upper, and spread a little under the midsole. Finally, the pull tab on the laces and the green "NIKE" brand logo on the collar also add vitality to this pair of sneakers, while the jagged spiked outsole adds appearance and helps complete the overall design.
Roots Analysis has announced the addition of “Modular Facilities in Pharmaceutical and Biotechnology Market (3rd Edition), 2023-2035” report to its list of offerings.
Key Market Insights
Presently, over 50 modular facility providers are engaged in the healthcare market, located across the globe
Currently, more than 250 modular cleanroom providers are offering controlled environments along with accessories in the healthcare domain
The partnership activity for modular facilities in healthcare domain has grown at a CAGR of over 30%, in the past three years, 2018-2021
The projected future opportunity for companies engaged in this field is expected to be well distributed across size of facility, type of industry served, type of modular construct, type of construction component, purpose of facility, scale of operation, type of product, type of expansion, type of modular construction, type of material used and key geographical regions.
An insightful competitiveness analysis of players involved in the modular facilities manufacturing in the healthcare domain
Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Historical Background
3.3. The Concept of Modular Facilities
3.3.1. Types of Modular Constructs
3.3.2. Modular Construction Process
3.4. Modular Construction in the Pharmaceutical Industry
3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
3.4.2. Modular Pharmaceutical Cleanrooms
3.4.2.1. Cleanroom Classifications and Current Standards
3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction
3.5. Advantages of Modular Cleanrooms
3.6. Challenges and Future Prospects
4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
4.1. Chapter Overview
4.2. Modular Facility Manufacturers: Overall Market Landscape
4.2.1 Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.2.6. Analysis by Type of Industry Served
4.2.7. Analysis by Geographical Coverage
4.2.8. Analysis by Type of Industry Served and Geographical Coverage
4.2.9. Analysis by GMP Compliance
4.2.10. Analysis by Geographical Coverage and GMP Compliance
4.2.11. Analysis by Type of Modular Construction
4.2.12. Analysis by Type of Industry Served and Type of Modular Construction
4.2.13. Analysis by Type of Material Used
4.2.14. Analysis by Type of Modular Construction and Type of Material Used
4.2.15. Analysis of Historical and Current Market Landscape Trends
4.2.15.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served
5. MARKET LANDSCAPE: MODULAR CLEANROOM PROVIDERS
5.1. Chapter Overview
5.2. Modular Cleanroom Providers: Overall Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Year of Establishment and Location of Headquarters
5.2.5. Analysis by Company Size and Location of Headquarters
5.2.6. Analysis by Type of Industry Served
5.2.7. Analysis by Location of Headquarters and Type of Industry Served
5.2.8. Analysis by Type of Modular Cleanroom Offered
5.2.9. Analysis by Type of Industry Served and Type of Modular Cleanroom Offered
5.2.10. Analysis by Type of Cleanroom Component Offered
5.2.11. Analysis by Type of Industry Served and Cleanroom Component Offered
5.2.12. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
5.2.13. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
5.2.14. Analysis by Quality Certifications Obtained
6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS
6.1 Chapter Overview
6.2 Assumptions / Key Parameters
6.3 Methodology
6.4 Company Competitiveness Analysis: Modular Facility Manufacturers
6.4.1. Company Competitiveness Analysis: Benchmarking of Service Strength
6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership activity
6.4.3. Company Competitiveness Analysis: Small Companies
6.4.4. Company Competitiveness Analysis: Mid-Sized Companies
6.4.5. Company Competitiveness Analysis: Large Companies
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Cytiva
7.2.1. Company Overview
7.2.2. Modular Facility-related Services
7.2.3. Modular Projects
7.2.4. Recent Developments and Future Outlook
7.3. G-Con Manufacturing
7.4. Germfree
7.5. IPM Technologies
7.6. KeyPlants
7.7. ModuleCo Pharma
7.8. NNE
7.9. Pharmadule
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Modular Facility Manufacturers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year of Partnership and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Modular Facility
8.3.7. Analysis by Type of Product and Type of Modular Facility
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Location of Partner’s Headquarters
8.3.10. Analysis by Location of Modular Facility
8.3.11. Analysis by Type of Partnership and Location of Modular Facility
8.3.12. Analysis by Type of Product and Location of Modular Facility
8.3.13. Intercontinental and Intracontinental Partnerships
8.3.14. Analysis by Country
9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
9.1. Chapter Overview
9.2. Modular Facility Projects Undertaken in the Pharmaceutical and Biotechnology Industry
9.3.1. Analysis by Type of Modular Facility
9.3.2. Analysis by Size of Modular Facility
9.3.3. Most Active Manufacturers: Analysis by Number of Projects Delivered
9.3.4. Most Active Clients: Analysis by Number of Projects Received
9.3.5. Analysis by Location of Modular Facility
9.3.6. Analysis by Type of Facility and Size of Modular Facility
9.3.7. Analysis by Client and Location of Facility
10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY
10.1. Chapter Overview
10.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry: Historical Data for Top 20 Players
10.2.1. Analysis by Number of Facilities Delivered
10.2.2. Analysis by Type of Facility
10.2.3. Analysis by Purpose of Facility
10.2.4. Analysis by Type of Facility and Purpose of Facility
10.2.5. Analysis by Type of Investment
10.2.6. Analysis by Purpose of Facility and Type of Investment
10.2.7. Analysis by Size of Facility
10.2.8. Analysis by Type of Facility and Size of Facility
10.2.9. Analysis by Purpose of Facility and Size of Facility
10.2.10. Analysis by Location of Headquarters
10.2.11. Analysis by Location of Facility
10.2.12. Analysis by Type of Facility and Location of Facility
11. COST-TIME OPTIMIZATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Factors Influencing Modular Construction
11.3.1. Intrinsic Factors
11.3.2. Extrinsic Factors
11.4. Cost Efficiency Analysis
11.5. Time-Benefit Analysis
11.6. Concluding Remarks
12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Modular Facilities Market in the Pharmaceutical / Biotechnology Sector,
2023-2035
12.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Size of Facility, 2023 and 2035
12.4.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-203
12.4.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035
12.4.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035
12.4.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035
12.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Industry Served, 2023 and 2035
12.5.1. Modular Facilities Market in the Pharmaceutical Industry, 2023-2035
12.5.2. Modular Facilities Market in the Biotechnology Industry, 2023-2035
12.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construct, 2023 and 2035
12.6.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035
12.6.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035
12.6.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035
12.6.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035
12.6.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035
12.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Construction Component, 2023 and 2035
12.7.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035
12.7.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Buildings, 2023-2035
12.7.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing Systems, 2023-2035
12.7.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035
12.7.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035
12.8 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Purpose of Facility, 2023 and 2035
12.8.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing, 2023-2035
12.8.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling, 2023-2035
12.8.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development, 2023-2035
12.8.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Purposes, 2023-2035
12.9. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Scale of Operation, 2023 and 2035
12.9.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Scale, 2023-2035
12.9.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Scale, 2023-2035
12.10. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Product, 2023 and 2035
12.10.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035
12.10.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035
12.10.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035
12.10.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035
12.10.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035
12.10.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035
12.10.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035
12.10.8. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035
12.11. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Facility, 2023 and 2035
12.11.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035
12.11.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035
12.11.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035
12.12. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construction, 2023 and 2035
12.12.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035
12.12.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035
12.13. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Material Used, 2023 and 2035
12.13.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035
12.13.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035
12.13.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035
12.14. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Geography, 2023 and 2035
12.14.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035
12.14.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035
12.14.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035
12.14.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035
12.14.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World,
2023-2035
12.15. Concluding Remaks
13. PREVALENT AND EMERGING INDUSTRY TRENDS
13.1. Chapter Overview
13.2. Adoption of Modular Facilities
13.3. Expansion of Existing Service Portfolio
13.4. Integration of Advanced Technologies
13.4.1. Single-use Technologies
13.4.2. Continuous Processing Technologies
13.4.3. Other Advanced Technologies
14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Visibility Amongst Start-Ups
14.3. Popularity Amongst Contract Manufacturing Organizations
14.4. Expansion of Existing Facilities
14.5. Adoption for Production of Biosimilars
14.6. Additional Opportunities
14.7. Key Growth Drivers for Modular Construction
14.8. Market Attractiveness in Emerging regions
15. CONCLUSION
16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Avon Modular
16.2.2. Interview Transcript: Alan de Zayas (Modular Building Manufacturing and Construction Team)
16.3. Environmental Systems Corporation
16.3.2. Interview Transcript: Vernon Solomon (President)
16.4. Exyte
16.4.2. Interview Transcript: François Abiven (Executive Vice President Global Business Unit BLS) and Luca Mussati (Vice President Technology and Innovation)
16.5. G-Con Manufacturing
16.5.2. Interview Transcript: Maik Jornitz (Chief Executive Officer)
16.6. Modular Devices
16.6.2. Interview Transcript: Mark Koers (Executive Vice President, Sales and Marketing)
16.7. ModWave
16.7.2. Interview Transcript: Pär Almhem (President)
16.8. Subzero Engineering
16.8.2. Interview Transcript: Ward Patton (Director of Sales)
16.9. Vernick
16.9.2. Interview Transcript: Wes Temple (Director of Marketing)
16.10. Zeton
16.10.2. Interview Transcript: Sulogna Roy (Ex-Sales Manager)
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/modular-manufacturing-market/178.html
You may also be interested in the following titles:
Pharmaceutical Polymers / Medical Polymers Market
Gene Switch Market
You may also like to learn what our experts are sharing in Roots educational series:
Digital Therapies: The “Digital Pills” of current generation
Medical Device Coatings and Modification Technologies
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
The growing concern of patient non-compliance and poor adherence to conventional medication regimen has prompted various biopharmaceutical companies to leverage the expertise of players offering long-acting drug delivery technologies and services
Roots Analysis is pleased to announce the publication of its recent study, titled, “Long-Acting Drug Delivery Market, 2023-2035”
The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes
An executive summary of the insights captured during our research. It offers a high-level view on the current state of long acting drugs delivery technologies and services market and its likely evolution in the mid-long term.
A general overview of long-acting drug delivery and the different types of long-acting drug delivery systems. Additionally, it highlights the underlying principles and strategies associated with long-acting drug delivery.
A detailed assessment of the current technology landscape of long-acting drug delivery technologies.
A detailed assessment of the overall service providers landscape of the companies offering contract services related to long-acting drug delivery.
A technology competitiveness analysis of long-acting drug delivery technologies.
A company competitiveness analysis of long-acting drug delivery service providers.
Elaborate profiles of prominent players developing technologies and offering services in the domain of long-acting drug delivery (shortlisted based on a proprietary criterion).
A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018.
A detailed analysis of over 570 peer-reviewed, scientific articles focused on research related to long-acting drug delivery.
An in-depth analysis of various patents that have been filed / granted related to long-acting drug delivery, since 2018.
A detailed review of academic grants that have been awarded to various research institutes for projects focused on long-acting drug delivery, since 2018.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Principle
Manipulation of drug release from delivery systems
Manipulation of in vivo clearance
Strategy
Chemical Modification
Micro-encapsulation
Long-Acting Hydrogels
Long-Acting Implants
Long-Acting Microneedles
Multivesicular Liposomes
Nanocrystal Suspensions
Protein Fusion
Compatible Dosage Form
Injectables
Implantables
Oral Dosage Forms
Topical / Transdermal Dosage Forms
Vaginal Dosage Forms
Other Dosage Forms
Type of Molecules Delivered
Small Molecules
Biologics
Other Molecules
Type of Material Used
Polymer based
Non-polymer based
Key Geographical Regions
North America
Europe
Asia-Pacific
Middle East and North Africa
Key companies covered in the report
Adare Pharma Solutions
AMW
Bostal Drug Delivery
Creative Biolabs
ForDoz Pharma
Innocore Pharmaceuticals
Integral BioSystems
LATITUDE Pharmaceuticals
Navin Saxena Research and Technology Centre (NSRT)
Samyang Biopharm
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market.html
You may also be interested in the following titles:
Oral Solid Dosage Manufacturing Market
Lipid Nanoparticles in Drug Delivery
Bioavailability enhancement services market
Global Gene Switch Market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
The rising demand for greater data reproducibility, accuracy and increased efficiency have prompted the healthcare laboratories to consider shifting from manually-handled processes to using lab automation systems.
Roots Analysis is pleased to announce the publication of its recent study, titled, “Lab Automation Market, 2023-2035”
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these lab automation systems over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
A detailed assessment of the current market landscape of lab automation system manufacturers engaged in the manufacturing of various lab automation systems.
A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength, product diversity and product strength.
Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation system across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.
An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software, mode(s) of deployment, end-user(s).
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Stage of Automation
Pre-Analytical Stage
Analytical Stage
Post-Analytical Stage
Total Lab Automation
Type of Instrument
Automated Liquid Handling Systems
Automated Microplate Readers
Automated Sampling Systems
Analyzers
Automated Storage and Retrieval Systems (ASRS)
Other Instruments
End-User
Pharmaceutical and Biotechnology Companies
Research and Diagnostic Laboratories
Other End-Users
Key Geographical Region
North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
Key companies covered in the report
Abbott
Anton Paar
BD
Beckman Coulter
ERWEKA
Leuze
Ortho Clinical Diagnostics
Pall Corporation
PerkinElmer
Roche Diagnostics
Siemens Healthineers
SYSTAG
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/lab-automation-market.html
News article
Digital Biomanufacturing Market
Learn from experts: do you know about these emerging industry trends?
SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases
Novel Cell Cytometers: Need of the Hour
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
The “Investor Series: Opportunities in Women’s Digital Health Market’’ report provides detailed information on the women’s digital health market, covering the core and peripheral women’s digital health solutions
Key Inclusions
An executive summary of the insights captured during our research. It offers a high-level view on the current state of women’s digital health market and its likely evolution in the mid-long term along with the financial activity in this domain.
An introduction to women’s digital health, highlighting some of the key application areas of the FemTech industry. It features various types of women’s digital health products / solutions that have either been marketed / are under development. In addition, the report highlights prominent barriers to the development and success of women’s digital health solutions, and the opinions of representatives from key stakeholder companies involved in this domain.
A detailed analysis of women’s digital health focused companies that were established post-2006, featuring key insights on the observed trends related to the basic company parameters, such as year of establishment, location of headquarters, company size, and type of venture.
An assessment of the various products / solutions, offered by the innovator companies, featuring analysis based on number and types of products. Based on the aforementioned insights, we have developed a quantitative perspective on the relative health (based on the company details, product portfolio, financing activity, estimated revenues and profits) of the different innovator companies that have been described in detail in this report. This analysis is based on a proprietary scoring criterion, informed via secondary research.
An informed perspective on the value proposition of the companies captured in the report based on multiple relevant aspects, namely product-related value, value to patients, developer value and outreach-related value.
A company competitiveness analysis, which offers a quantitative basis for comparing the strengths / contributions of various industry stakeholders that are involved in providing women’s digital health solutions. It is worth mentioning that this analysis is based on the insights generated from the abovementioned relative health indexing and value proposition analysis.
A detailed analysis of the women's digital health funding women's digital health investment activity that has taken place, since 2011. It also includes category-wise financing trends, describing the relative maturity (in terms of number of funding instances and total capital raised) of the innovator companies mentioned in the report. Further, it features a list of the leading investors in women’s digital health, based on their participation in financing activity in this industry segment.
An elaborate review of the overall women’s digital health market from a financial perspective, including detailed fundamental (insights from the balance sheet and key financial ratios) and technical analysis (insights from historical and recent stock price variations as well as analysis using popular stock performance indicators) of financial data of the publicly listed companies within the innovators landscape dataset.
A key acquisition targets analysis, based on the insights generated during the course of this study, highlighting some of the promising early-to-mid stage business ventures that are likely to be acquired / merged.
A case study on the assessment of business risks, based on some of the major risk categories that are usually discussed in the industry, namely operations-related risks, business-related risks, financial / asset-related risks, product / technology risks, and others (social, economic, environmental and political risks).
A case study where investors have exited various women’s digital health-related ventures, offering insights on return on investments received (based on availability of data). Leveraging the abovementioned details, the report offers an informed opinion on the future outlook for investors in the women’s digital health market.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
Type of Solution
Applications / Software
Devices
Services
Therapeutic Application Area
Fetal Health
General Wellness
Menstrual Cycle
Pelvic Care
Reproductive Health / Fertility
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Key Questions Answered
What are the key application areas of the FemTech industry?
Who are the innovators offering women’s digital health solutions?
What type of women’s digital health products / solutions are being offered by the innovator companies?
What are the key value propositions offered by players engaged in the women’s digital health domain?
What is the relative competitiveness of different players offering products / solutions focused on women’s health?
Who are the key investors that are actively supporting the development and commercialization of women’s digital health products / solutions?
What are the anticipated fundamental and technical trends of financial data of publicly listed companies within the innovator landscape?
Who are the potential acquisition targets for investors in the women’s digital health sector?
What are the major risks for investors seeking to tap into the women’s digital health domain?
What is the estimated return on investments received by the investors?
How is the current and future market opportunity related to women’s digital health likely to be distributed across key market segments?
Get more details on the report https://www.rootsanalysis.com/reports/opportunities-in-women-digital--health-market.html
You may also be interested in the following titles:
Blockchain Technology in Healthcare Market
Autoinjectors
You may also like to learn what our experts are sharing in Roots educational series:
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
4D Bioprinting Market: Key Trends
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
The new market report titled “Opportunities in the RNA Therapeutics Market”, published by Roots Analysis is one of the most sought-after solutions for investors operating in the RNA therapeutics market.
The report will help investors stay updated with the latest market trends and opportunities associated with the RNA therapeutics market. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, innovator and product landscape, company health indexing, value proposition analysis, company competitiveness, funding and investment, financial analysis of public ventures, business risk analysis, returns on investment and key acquisition targets, as well as the emerging market trends and opportunities in RNA therapeutics market. The opportunities in the RNA therapeutics market are anticipated to expand significantly.
However, the latest report is mainly intended for business leaders, experts, thought leaders, investors, start-ups and growth stage firms interested in RNA Therapeutics business space and is available in the form of PDF and spreadsheet.
Investor Series: Opportunities in the RNA Therapeutics Market:
Investor Series Scope and Market Size:
The report provides detailed information on the RNA therapeutics market, covering the core and peripheral RNA therapeutics solutions. It offers a technical and financial perspective on how the RNA therapeutics market opportunities is likely to evolve, in terms of future business success, over the coming decade. The RNA therapeutics market is broadly segmented on the basis of type of solution, type of therapy, therapeutic area and geographical regions. The segmental growth helps the investors, firms, business leaders to get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the RNA therapeutics market in terms of market size & volume and significant information pertaining to product bifurcation and RNA therapeutics solutions overview.
Key Market Contenders:
This particular section of the RNA therapeutics market report covers all the necessary details of the RNA therapeutics’ solutions developed by players operating in the RNA therapeutics market. The report goes on to elucidate a quantitative perspective on the relative health of the different innovator companies and an assessment of the various solutions, offered by the companies developing DTx solutions, featuring analysis based on number and types of products, and an informed perspective on the value of the offerings based on multiple relevant aspects.
Information on the funding and investment activity that has taken place in this domain since 2011 has also been included in this report. Moreover, the exhaustive report presents financing category-wise trends, describing the relative maturity of the innovator companies. Further, RNA therapeutics market features a list of the leading RNA therapeutics investors , based on their participation in financing activity in this industry segment. It also covers an elaborate review of the overall RNA therapeutics market from a financial perspective, including detailed fundamental (insights from the balance sheet, and key financial ratios) and technical analyses (insights from historical and recent stock price variations, and analysis using popular stock performance indicators) of financial data of the publicly listed companies.
This section of RNA therapeutics market report focusing on the competitive terrain of the RNA therapeutics market endows the reader with every significant detail and information about the leading competitors on the market. The report provides a key acquisition targets analysis, highlighting some of the promising early-to-mid stage business ventures around which there is likely to be interest for future acquisitions / mergers and also includes the case study of instances where investors have exited various RNA therapeutics related ventures, offering insights on return on investments made. Leveraging the abovementioned details, the report offers an informed opinion on the future outlook for investors in the RNA therapeutics market.
Section covered in RNA therapeutics market report:
Section 01: Need for RNA Therapeutics and Innovators Landscape
Section 02: Analysis of Investments
Section 03: Financial Analysis and Assessment of Business Risks
Section 04: Market Forecast and Opportunity Analysis
Section 05: Analysis of Returns on Investment and Key Acquisition Targets
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/opportunities-in-RNA-therapeutics-market.html
You may also be interested in the following titles:
Oral Solid Dosage Manufacturing Market
Lipid Nanoparticles in Drug Delivery
You may also like to learn what our experts are sharing in Roots educational series:
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
4D Bioprinting Market: Key Trends
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Roots Analysis has done a detailed study on Gene Switch Market, 2023-2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
Key Market Insights
Presently, close to 50 gene switch platforms are being developed for various applications in adoptive cell therapies (ACT), including CAR-Ts, TCRs and gene therapies; majority of them are protein-based gene switches
Various small molecules, including rimiducid, rapamycin and dasatinib, are being investigated to design safety switch for ACTs; management of treatment related toxicity has emerged as the key application of such platforms
The current market landscape is fragmented, featuring the presence of both new entrants and established players; presently, majority of the gene switch platform developers are based in North America
In pursuit of gaining a competitive edge, gene switch developers are presently undertaking several initiatives to expand their existing capabilities and augment respective product portfolios
The growing interest in this domain is evident from the rise in licensing agreements over the last few years; majority of such deals were signed between players based in North America
Several investors, having realized the opportunity within this domain, have invested over USD 3.5 billion across various funding rounds in the past five years
Scientific articles being published for gene switch, reflect the growing research efforts of various industry and academic stakeholders; majority of the authors are affiliated to organizations based in North America
More than 360 patents have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field since 2014
Based on historical trends, we expect a steady growth in the licensing of gene switch platforms, in order to meet the growing demand for safe and effective gene therapies
The gene switch market is expected to grow at a CAGR of 11.5% till 2035; the overall opportunity is anticipated to be well distributed across various segments, such as types of target therapies, application areas and key regions
Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Key Questions Answered
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Emergence of Gene Switch
3.3. Applications of Gene Switch
3.4. Challenges Associated with Gene Switch
3.5. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Gene Switch Platforms: Overall Market Landscape
4.3. Gene Switch Platform Developers: Developer Landscape
5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Product Competitiveness Analysis: Gene Switch Platforms
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. aceRNA Technologies
6.2.1. Company Overview
6.2.2. Gene Switch Platform Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Autolus Therapeutics
6.4. Bellicum Pharmaceuticals
6.5. Cellectis
6.6. Kiromic BioPharma
6.7. panCELLa
6.8. Precigen
6.9. Sana Biotechnology
6.10. Sangamo Therapeutics
7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Gene Switch Platforms: Partnerships and Collaborations
8. FUNDING AND INVESTMENT ANALYSIS
8.1. Chapter Overview
8.2. Type of Funding
8.3. Gene Switch Platforms: Funding and Investments Analysis
9. PUBLICATION ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Gene Switch Platforms: Recent Publications
10. PATENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Gene Switch Platforms: Patent Analysis
10.4. Gene Switch Platforms: Patent Benchmarking Analysis
10.5. Gene Switch Platforms: Patent Valuation
10.6. Leading Patents: Analysis by Number of Citations
11. BUSINESS MODEL ANALYSIS
11.1. Chapter Overview
11.2. Gene Switch Platform Developers: Business Model Analysis
11.3. Concluding Remarks
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Global Gene Switch Platform Market, 2023-2035
13. CONCLUDING REMARKS
14. APPENDIX 1: TABULATED DATA
15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/gene-switch-market.html
Learn from experts: do you know about these emerging industry trends?
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
Medical Device Coatings and Modification Technologies
Learn from our recently published whitepaper:-
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Günstig Trikots Fußball Kinder, Frenkie de Jong ist entschlossen, diesen Sommer bei Barcelona zu bleiben, obwohl er enge Beziehungen zu Manchester United unterhält. De Jong, der aufgrund des Spiels im letzten Monat gegen die Niederlande eine zusätzliche Sommerpause erhielt, wird nächste Woche ins Saisonvorbereitungstraining zurückkehren. United befindet sich noch in Gesprächen mit La Blaugrana über einen möglichen Deal, aber De Jong will bis zur Saison 2022/23 in Katalonien bleiben. Trotz Spekulationen wird der ehemalige Ajax-Star wahrscheinlich eine Gehaltskürzung benötigen, um im Camp Nou zu bleiben. Laut Daily Sport hat der 25-Jährige einen Zehn-Punkte-Plan, um Manchester United abzulehnen. Zu den aufgeführten Gründen gehörten persönliche Faktoren, darunter der Kauf eines neuen Hauses und Engagements, sowie sein Traum, ein Starspieler für seinen Traumclub Barcelona zu werden. Aus United-Sicht will er in der Champions League spielen, ihm fehlt aber das Selbstvertrauen, im Old Trafford unter seinem ehemaligen Chef Eric Ten Hager sofort das Ruder herumzureißen.
Italien Trikots, Giovani Lo Celso wurde aufgrund seines dauerhaften Wechsels zu Villarreal aus Tottenhams Kader für die Saisonvorbereitung ausgeschlossen. Der argentinische Nationalspieler kam im Januar auf Leihbasis zu den Yellow Submarines und wird in der zweiten Hälfte der Saison 2021/22 zu einem Schlüsselspieler für Unai Emery. Die beiden Klubs haben an einem Transfervertrag mit Spurs-Chef Antonio Conte gearbeitet, der Yves Bissouma zu seinem Nachfolger gemacht hat.
Barcelona Kindertrikot, Laut „Marca“-Bericht reist Tottenham Hotspur in den nächsten Wochen für zwei Aufwärmspiele nach Südkorea, Villarreal will nun versuchen, die Ablöse von 30 Millionen Euro für Lo Celso abzuschließen. Lo Celso ist nicht der einzige große Name, den Conte ausgelassen hat, auch Tanguy Ndombele, Harry Winks und La Roja-Nationalspieler Sergio Reguilon bleiben in London. Reguilon, der seit Contes Ankunft nicht mehr im Kader der ersten Mannschaft steht, könnte von einer Rückkehr in die La Liga in Versuchung geführt werden, wenn ein Angebot gemacht wird.
In the New Jordan 2020, Nike Umbrellas have gradually launched their Lunar New Year products. Moreover, unlike the Air Jordan 1 Low OG and Air Jordan 1 Low OG, which both visually interpret the meaning of the "Year of the Tiger", the newly launched Blazer Mid takes "invisible, invisible, infinite" as the theme and draws inspiration from craftsmanship. Like Air Force 1, the back of the Blazer Mid is decorated with three jade stones, and their unique shapes are likely to represent the above three themes. In addition, the quilted upper has its own trio of gray, pink and blue. The bright red Swooshes and the words "Nike" on the side and heel labels respectively create an auspicious atmosphere, while also complementing the extra lace around the collar.
2020 Cheap Jordans, Nike Air Force 1 was born in 1982, and it has just passed 39 years. In the sneaker village, there are not many shoes that can retain heat for decades like the Nike Air Force 1, and even shoes of other brands are only a few. In fact, the current hot trend is shoes like NMD or MLB Boston, but no one can be sure whether these shoes will be as popular as Nike Air Force 1. To celebrate the 40th anniversary of Bruce Kilgore's iconic Air Force 1, Nike released a series of limited edition sneakers. The first version to be unveiled will be the Nike Air Force 1 Mid shoe dedicated to Paris, the city of love.
Retro Jordan 2021, The Nike Air Force 1 Mid "Paris" will be made of cream suede with a light yellow overlay. The Nike Swoosh logo on the side of the shoe, the heel loop and the tongue are embellished in blue and green. The pattern is related to the city street signs, and the number "75" is the characteristic. The embroidery on the forefoot part will match the city's zip code. Next, the metal eyelets are an homage to the iconic streets of Paris. Take a closer look, the triangular hole at the toe-may refer to the Louvre. Finally, the combination of cream midsole and yellow outsole will help complete the overall appearance of this pair of sneakers.
New Jordan Release, Jordan Brand is one of the world's leading sportswear brands. Air Jordan 1 is famous for its extremely fashionable, eye-catching and creative design, and has always been enthusiastically loved by fans. Especially the Air Jordan 1 High shoe series, which is extremely easy to use and not fussy about users. It is one of Jordan Brand's best-selling shoe series. One of the latest editions of Jordan Brand will be an exclusive women's version of the Air Jordan 1 Low called "Marina Blue". The coveted design has recently been renewed in a crater style through the use of recycled materials. The Nike Dunk Low named "Dark Marina Blue" will mainly be covered in navy tones, and the toe and reeds will appear in this vivid tone. Leather covering. Next, like the Dunk Low "Kentucky" version, the blue tone will continue to highlight the Nike Swoosh logo on the side of the shoe, the tongue border, the Jumpman logo, and the found number "23" and other details. The laces are fixed. Finally, the combination of white midsole and blue outsole will help complete the overall appearance of this pair of sneakers.
The latest report entitled ‘DNA and Gene Cloning Services Market’ by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe.
The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies currently adopted by them. The report is a granular assessment of this particular business sphere and entirely covers the dynamic competitive landscape of the market. The document offers key insights into the market positions of these players alongside their gross earnings. Furthermore, it elaborates on each of the market segments, with detailed scrutiny of the development scope and competitive scenario of the regional fragments of the market.
The latest study is inclusive of an in-depth analysis of the economic status of the DNA and Gene Cloning Services market and examines the most important regions constituting the global market. It further details on the most lucrative and growth-oriented regions, top market rivals, diversified product types, and a large number of end-use industries.
Key factors affecting the growth of the DNA and Gene Cloning Services market:
Geographical Overview:
The latest report broadly categorizes the DNA Cloning and Gene Cloning Services market into several geographical terrains, including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The study is inclusive of essential information relevant to each region in this broad industry segment, along with the key drivers of the regional market growth.
The report further estimates the revenue accumulated by these regions over the forecast period.
Competitive Hierarchy:
The latest research report studies the major market players, their regional presence, industry share, and production facilities.
The report offers significant data pertaining to these market competitors’ company profiles, product types, and application outlook.
Moreover, the pricing models and gross margins of these industry majors have also been mentioned in the report.
Additional parameters of the DNA and Gene Cloning Services market report:
The latest research study endows the reader with a comprehensive analysis of the product types of the DNA and Gene Cloning Services market, categorizing the relevant information into the market share, production growth rate, and profit valuation of each product type. The study focuses on the wide-ranging application landscape of the market, segmenting it into the market share, estimated growth rate, and the forecast product demand for each application type.
Additional Insights:
The market concentration rate and processing rate of raw materials have also been conscripted in the report.
The report contains an assessment of the current price trends, as well as the factors influencing the global market size.
It throws light on the significant marketing strategies implemented by the eminent players in the industry.
Vital data and information concerning the producers, distributors, and downstream buyers involved in the global market, as well as the cost structure analysis and market mechanism, form the important elements of this report.
Research objectives:
The DNA and Gene Cloning Services market report studies the worldwide market consumption rate in terms of value and volume.
It identifies the various sub-segments of the market structure.
It proffers information regarding the leading global manufacturers in this industry, describing their market value & share, sales volume, competitive analysis, SWOT analysis, and development strategies adopted during the forecast timeline.
The report describes the key industry players, with respect to their individual growth trends, future prospects, and contribution to the global market, and explains the factors related to their market growth potential, drivers, opportunities, threats, and industry-specific challenges.
Furthermore, the report underpins the strategic developments occurring in the DNA and Gene Cloning Services market, such as expansions, mergers & acquisitions, agreements, as well as new product launches.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/dna-and-gene-cloning-market.html
You may also be interested in the following titles:
Oral Proteins and Peptides Market
Modular Manufacturing Facilities Market
You may also like to learn what our experts are sharing in Roots educational series:
Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities
Investment Opportunities in Women’s Digital Health
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#DNAandGeneCloningServicesMarketTrends #DNAandGeneCloningServicesMarketShare #GeneCloningServicesMarket #molecularcloningservices #genesynthesisandcloning
Given the potential of digital twins to replicate the physical world in a digital layout, as well as their ability to provide real-time outputs, while gathering constant inputs from the real-world, such products have generated significant interest within the healthcare domain
The USD 29.8 billion (by 2035) financial opportunity within digital twin market has been analyzed across the following segments:
Therapeutic Area
Cardiovascular Disorders
Metabolic Disorders
Orthopedic Disorders
Other Disorders
Type of Digital Twin
Process Twins
System Twins
Whole Body Twins
Body Part Twins
Area of Application
Asset / Process Management
Personalized Treatment
Surgical Planning
Diagnosis
Other Applications
End Users
Pharmaceutical Companies
Medical Device Manufacturers
Healthcare Providers
Patients
Other End Users
Key Geographical Regions
North America
Europe
Asia
Latin America
Middle East and North Africa
Rest of the World
The Digital Twins Market, 2022-2035, report features the following companies, which we identified to be key players in this domain:
Babylon
ExactCure
ImmersiveTouch
Navv Systems
ThoughtWire
Unlearn.AI
The latest report also provides key insights for Digital Twin Technology and Digital Twins Providers
Table of Contents
Preface
Executive Summary
Introduction
Market Landscape
Key Insights
Company Competitiveness Analysis
Company Profiles
Partnerships and Collaborations
Funding and Investments Analysis
Berkus Start-up Valuation Analysis
Market Forecast
Conclusion
Executive insights
Appendix I: Tabulated data
Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/digital-twins-market.html
You may also be interested in the following titles:
Buffer Preparation Market
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Quantum Computing in Drug Discovery Services Market
Roots Analysis Consulting - the preferred research partner for global firms
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Roots Analysis has done a detailed study on “AI-based Digital Pathology Market, 2022-2035”, covering key aspects of the market’s evolution and identifying potential future growth opportunities.
Key Market Insights
Presently, close to 80 players offering AI-based digital pathology services are available in the healthcare market which are located across the globe
In order to tap into the lucrative opportunity associated with AI-based digital pathology, various investment firms have invested over USD 1.7 billion in AI-based digital pathology market space, during the period 2016-2022
The estimated global demand for AI-based digital pathology is expected to grow at a CAGR of 9,4%, during 2022-2035
The projected future opportunity for companies engaged in this field is expected to be well distributed across different types of neural networks, types of assay, end-users, areas of applications, target disease indications, and key geographical regions
Table of Contents
1. PREFACE
1.1. Chapter Overview
1.2. Market Segmentations
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Artificial Intelligence in Digital Pathology
3.3. Workflow of AI-based Digital Pathology
3.4. Applications of AI-based Digital Pathology Solutions
3.5. Regulatory Requirements Focused on AI-based Digital Pathology:
3.6. Challenges Associated with the Use of AI in Digital Pathology
3.7. Future Perspectives
4. AI-BASED DIGITAL PATHOLOGY: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. AI-based Digital Pathology Providers: Developers Landscape
4.3. AI-based Digital Pathology Providers: Market Landscape
5. AI-BASED DIGITAL PATHOLOGY MARKET: KEY INSIGHTS
5.1. Chapter Overview
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. PathAI
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. Paige
6.4. Akoya Biosciences
6.5. PROSCIA
6.6. Visiopharm
6.7. Roche Tissue Diagnostics
6.8. Aiforia Technologies
6.9. Indica Labs
6.10. Ibex Medical Analytics
7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Benchmarking of Portfolio Strength
7.5. Benchmarking of Funding Strength
7.6. Company Competitiveness Analysis: Small Players
7.7. Company Competitiveness Analysis: Mid-sized Players
7.8. Company Competitiveness Analysis: Large Players
8. FUNDING AND INVESTMENTS
8.1. Chapter Overview
8.2. Types of Funding
8.3. AI-based Digital Pathology: List of Funding and Investments
8.4. Concluding Remarks
9. DEMAND ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Global Demand for AI-based Digital Pathology, 2022-2035
9.4. Demand for AI-based Digital Pathology: Analysis by Geography
9.5. Demand for AI-based Digital Pathology: Analysis by Type of End-user
9.6. Concluding Remarks
10. MARKET SIZING AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global AI-based Digital Pathology Market, 2022-2035
10.4. AI-based Digital Pathology Market: Analysis by Type of Neural Network, 2022 and 2035
10.5. AI-based Digital Pathology Market: Analysis by Type of Assay, 2022 and 2035
10.6. AI-based Digital Pathology Market: Analysis by Type of End-user, 2022 and 2035
10.7. AI-based Digital Pathology Market: Analysis by Area of Application, 2022 and 2035
10.8. AI-based Digital Pathology Market: Analysis by Target Disease Indication, 2022 and 2035
10.9. AI-based Digital Pathology Market: Analysis by Key Geographies, 2022 and 2035
11. CONCLUDING REMARKS
12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. aetherAI
12.3. CTL Clinitech Lab
12.4. Huron Digital Pathology
12.5. Mindpeak
12.6. Pramana
13. APPENDIX 1: TABULATED DATA
14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/ai-based-digital-pathology-market.html
Learn from experts: do you know about these emerging industry trends?
TIL Therapies: A New Paradigm in Cancer Treatment
Viral Clearance and Viral Testing Services
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Roots Analysis has done a detailed study on Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market, covering important aspects of the industry and identifying key future growth opportunities.
Key Market Insights
Presently, more than 70 players across the globe claim to offer deep learning technologies for potential applications across various steps of drug discovery and development process
Majority (70%) of the stakeholders employ proprietary deep learning-based technologies in drug discovery to offer big data analysis
Nearly 50% of the deep learning-based diagnostic providers are based in North America; most such players offer technologies for use across medical imaging and medical diagnosis related applications
Around 70% of the players engaged in offering deep learning solutions for diagnostics have been established post-2011; majority of the players offer solutions focused on oncological disorders
Foreseeing the lucrative potential, a large number of players have made investments worth over USD 15 billion, across 210 funding instances, to advance the initiatives undertaken by industry stakeholders
Over the past few years, more than 704,000 patients have been recruited / enrolled in clinical trials registered for deep learning-based solutions / diagnostics across different geographies
Our proprietary benchmarking analysis, based on a variety of parameters, indicates the leading start-ups / small firms that are spearheading innovation in this domain
Some players have managed to establish strong competitive positions; in the near future, we expect multiple acquisitions to take place wherein the relative valuation of a firm is likely to be a key determinant
Increasing adoption of deep learning technologies in the life sciences and healthcare industry is anticipated to create profitable business opportunities for the technology developers
The market opportunity associated with deep learning in drug discovery is expected to witness an annualized growth rate of 23% over the coming 12 years
In the long term, the opportunity for deep learning in diagnostics is projected to grow exponentially; the market is likely to be well distributed across various therapeutic areas and geographical regions
Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Humans, Machines and Intelligence
3.2. The Science of Learning
3.3. The Big Data Revolution
3.4. Deep Learning in Healthcare
3.5. Concluding Remarks
4. MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY
4.1. Chapter Overview
4.2. Deep Learning in Drug Discovery: Overall Market Landscape of Service / Technology Providers
5. MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS
5.1. Chapter Overview
5.2. Deep Learning in Diagnostics: Overall Market Landscape of Service / Technology Providers
6. COMPANY PROFILES
6.2. Aegicare
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Aiforia Technologies
6.4. Ardigen
6.5. Berg
6.6. Google
6.7. Huawei
6.8. Merative
6.9. Nference
6.10. Nvidia
6.11. Owkin
6.12. Phenomic AI
6.13. Pixel AI
7. PORTER’S FIVE FORCES ANALYSIS
7.1. Chapter Overview
7.2. Methodology and Assumptions
7.3. Key Parameters
7.4. Concluding Remarks
8. CLINICAL TRIAL ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3 Deep Learning Market: Clinical Trial Analysis
9. FUNDING AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. Deep Learning Market: Funding and Investment Analysis
10. START-UP HEALTH INDEXING
10.1. Chapter Overview
10.2. Start-ups Focused on Deep Learning in Drug Discovery
10.3. Benchmarking Analysis of Start-ups Focused on Deep Learning in Drug Discovery
10.4. Start-ups Focused on Deep Learning in Diagnostics
10.5. Benchmarking Analysis of Start-ups Focused on Deep Learning in Diagnostics
10.5.1. Analysis by Focus Area
11. COMPANY VALUATION ANALYSIS
11.1. Chapter Overview
11.2. Company Valuation Analysis: Key Parameters
11.3. Methodology
11.4. Company Valuation Analysis: Roots Analysis Proprietary Scores
12. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Overall Deep Learning in Drug Discovery Market, 2023-2035
13. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Overall Deep Learning in Diagnostics Market, 2023-2035
14. DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS
15. CONCLUDING REMARKS
16. INTERVIEW TRANSCRIPTS
16.1. Chapter Overview
16.2. Nucleai
16.3. Mediwhale
16.4. Arterys
16.5. AlgoSurg
16.6. ContextVision
16.7. Advenio Technosys
16.8. Arterys
16.9. Arya.ai
17. APPENDIX 1: TABULATED DATA
18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/deep-learning-in-drug-discovery-market/156.html
You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market
Exploring AI-based Digital Pathology
Medical Device Coatings Market
Roots Analysis Consulting - the preferred research partner for global firms
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com